TAUNS Laboratories (197A) · TargetReframedLatest Earnings (2026-08-13): "Cited as achieved"
Management indicators focused on revenue, profit, profit margin and EBITDA
First written in FY2024. 1 of 4 entries say "Reframed", first in FY2025. Latest entry: 2026-08-13.
4entries
3years
2from disclosures
How it moved
Same theme, other companies
Performance Management Using Revenue, EBITDA and ROEA theme 38 companies write about · 1 as a headwind · 36 as a tailwind
The whole theme swung hardest in 2024: 4 of 29 companies on the "Worse" side.
0 other companies' latest entry also says "Cited as achieved".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 38 companies compared. The sentences above are computed from all 38.Full recordFilings, disclosures and news, newest first
- FY2025ReframedAnnual report
「The management metrics emphasized in formulating the medium-term management plan are revenue, operating profit, net income, operating margin, EBITDA, and ROE.」
The emphasized metrics changed from EBITDA margin to ROE. The company also disclosed a 44.4% operating margin, 48.2% EBITDA margin, and 40.7% ROE for the fiscal year ended June 2025. - FY2024First statedAnnual report
「The management metrics emphasized in formulating the medium-term management plan are revenue, operating profit, net income, operating margin, EBITDA, and EBITDA margin.」
The company lists the metrics to be emphasized in future medium-term management plans without setting specific numerical targets.